Global Clostridium Vaccine (Animal Health) Market Research Report 2022

Clostridium vaccines are used to provide immunity against for a variety of ovine and bovine clostridial diseases such as tetanus, black disease, pulpy kidney (enterotoxaemia), and blackleg.
Due to the COVID-19 pandemic, the global Clostridium Vaccine (Animal Health) market size is estimated to be worth US$ 417.7 million in 2021 and is forecast to a readjusted size of US$ 521.8 million by 2028 with a CAGR of 2.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Clostridium Vaccine (Animal Health) market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Clostridium Vaccine (Animal Health) landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Bovine accounting for % of the Clostridium Vaccine (Animal Health) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Veterinary Clinic segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Clostridium Vaccine (Animal Health) include Bayer, Bimeda, Boehringer Ingelheim, Ceva, Elanco, Merck Animal Health, Sanofi S.A., Virbac and Zoetis. etc. In terms of revenue, the global 3 largest players have a % market share of Clostridium Vaccine (Animal Health) in 2021.
This report focuses on Clostridium Vaccine (Animal Health) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Clostridium Vaccine (Animal Health) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Clostridium Vaccine (Animal Health) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Bovine
Ovine
Caprine
Swine
Poultry
Segment by Application
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Bayer
Bimeda
Boehringer Ingelheim
Ceva
Elanco
Merck Animal Health
Sanofi S.A.
Virbac
Zoetis